Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System An evaluation of the safety and performance of the STANZA Drug-eluting Resorbable Scaffold (DRS) system for the treatment of patients with obstructive superficial femoral artery disease.

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries: To describe the pharmacokinetics of paclitaxel in the blood delivered from a paclitaxel coated percutaneous angioplasty balloon catheter as a result of treatment of de novo or restenotic l...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

EMBA Peripheral Embolization Device ("EPED") Study This is an open label, acute, non-randomized, prospective, "first in man" (FIM) single-center study of the EMBA Medical Peripheral Embolization Device (PED).

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Zilver PTX Delivery System The objective of this study is to evaluate the performance of the Zilver PTX stent thumbwheel delivery system.

• Pays Australia, Germany, New Zealand
• Organes Aucun
• Spécialités Aucune

Safety and Feasibility Study of the Shockwave Lithoplasty System To study the early safety and performance of the Shockwave Medical System in subjects to demonstrate that the device can safely and effectively deliver localized energy for the treatment o...

• Pays New Zealand
• Organes Aucun
• Spécialités Aucune

PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass To assess the safety of performing a percutaneous fem-pop bypass using the PQ Bypass Guidewire Delivery System and commercially available stent grafts.

• Pays New Zealand
• Organes Aucun
• Spécialités Aucune

Aorfix Intelliflex First in Human Study The First In Human (FIH) study is a long-term, single center, non-randomized study established by Lombard Medical, Inc. to collect "on-label" data in the clinical setting on patients under...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune